148 related articles for article (PubMed ID: 32330555)
1. Higher PIK3C2B gene expression of H1N1+ specific B-cells is associated with lower H1N1 immunogenicity after trivalent influenza vaccination in HIV infected children.
Cotugno N; Zicari S; Morrocchi E; de Armas LR; Pallikkuth S; Rinaldi S; Ruggiero A; Manno EC; Zangari P; Chiriaco M; Bernardi S; Andrews SF; Cagigi A; Rossi P; McDermott AB; Pahwa S; Palma P
Clin Immunol; 2020 Jun; 215():108440. PubMed ID: 32330555
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of T and B memory cell responses elicited by the pandemic H1N1 vaccine in HIV-infected and HIV-uninfected individuals.
Sun P; Crum-Cianflone NF; Defang G; Williams M; Ganesan A; Agan BK; Lalani T; Whitman T; Brandt C; Burgess TH
Vaccine; 2017 Oct; 35(45):6103-6111. PubMed ID: 28987439
[TBL] [Abstract][Full Text] [Related]
3. Artificial Intelligence Applied to
Cotugno N; Santilli V; Pascucci GR; Manno EC; De Armas L; Pallikkuth S; Deodati A; Amodio D; Zangari P; Zicari S; Ruggiero A; Fortin M; Bromley C; Pahwa R; Rossi P; Pahwa S; Palma P
Front Immunol; 2020; 11():559590. PubMed ID: 33123133
[TBL] [Abstract][Full Text] [Related]
4. Response to 2009 pandemic influenza A (H1N1) vaccine in HIV-infected patients and the influence of prior seasonal influenza vaccination.
Soonawala D; Rimmelzwaan GF; Gelinck LB; Visser LG; Kroon FP
PLoS One; 2011 Jan; 6(1):e16496. PubMed ID: 21304982
[TBL] [Abstract][Full Text] [Related]
5. Long-term seroprotective response of trivalent seasonal influenza vaccine in HIV-infected children, regardless of immunogenicity before immunisation.
Moolasart V; Manosuthi W; Ausavapipit J; Chottanapund S; Likanonsakul S; Uttayamakul S; Srisopha S; Lerdsamran H; Puthavathana P
Int J STD AIDS; 2016 Aug; 27(9):761-8. PubMed ID: 26138900
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional and Immunologic Correlates of Response to Pandemic Influenza Vaccine in Aviremic, HIV-Infected Children.
de Armas LR; George V; Filali-Mouhim A; Steel C; Parmigiani A; Cunningham CK; Weinberg A; Trautmann L; Sekaly RP; Cameron MJ; Pahwa S
Front Immunol; 2021; 12():639358. PubMed ID: 33868267
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of IL-21 receptor on B cells and IL-21 secretion distinguishes novel 2009 H1N1 vaccine responders from nonresponders among HIV-infected persons on combination antiretroviral therapy.
Pallikkuth S; Pilakka Kanthikeel S; Silva SY; Fischl M; Pahwa R; Pahwa S
J Immunol; 2011 Jun; 186(11):6173-81. PubMed ID: 21531891
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity and sustainability of the immune response in Brazilian HIV-1-infected individuals vaccinated with inactivated triple influenza vaccine.
Souza TM; Santini-Oliveira M; Martorelli A; Luz PM; Vasconcellos MT; Giacoia-Gripp CB; Morgado M; Nunes EP; Lemos AS; Ferreira AC; Moreira RI; Veloso VG; Siqueira M; Grinsztejn B; Camacho LA
J Med Virol; 2016 Mar; 88(3):426-36. PubMed ID: 26267817
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and immunogenicity of influenza vaccine in HIV-infected children: a randomized, double-blind, placebo controlled trial.
Madhi SA; Dittmer S; Kuwanda L; Venter M; Cassim H; Lazarus E; Thomas T; Liberty A; Treurnich F; Cutland CL; Weinberg A; Violari A
AIDS; 2013 Jan; 27(3):369-79. PubMed ID: 23032417
[TBL] [Abstract][Full Text] [Related]
10. Absence of cross-reactive antibodies to influenza A (H1N1) 2009 before and after vaccination with 2009 Southern Hemisphere seasonal trivalent influenza vaccine in children aged 6 months-9 years: a prospective study.
McVernon J; Laurie K; Barr I; Kelso A; Skeljo M; Nolan T
Influenza Other Respir Viruses; 2011 Jan; 5(1):7-11. PubMed ID: 21138535
[TBL] [Abstract][Full Text] [Related]
11. Acquired immune responses to the seasonal trivalent influenza vaccination in COPD.
Staples KJ; Williams NP; Bonduelle O; Hutton AJ; Cellura D; Marriott AC; Combadière B; Wilkinson TMA
Clin Exp Immunol; 2019 Oct; 198(1):71-82. PubMed ID: 31161649
[TBL] [Abstract][Full Text] [Related]
12. Relation of activation-induced deaminase (AID) expression with antibody response to A(H1N1)pdm09 vaccination in HIV-1 infected patients.
Cagigi A; Pensieroso S; Ruffin N; Sammicheli S; Thorstensson R; Pan-Hammarström Q; Hejdeman B; Nilsson A; Chiodi F
Vaccine; 2013 Apr; 31(18):2231-7. PubMed ID: 23499520
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone®) administered by intradermal and intramuscular route in healthy adults.
Frenck RW; Belshe R; Brady RC; Winokur PL; Campbell JD; Treanor J; Hay CM; Dekker CL; Walter EB; Cate TR; Edwards KM; Hill H; Wolff M; Leduc T; Tornieporth N
Vaccine; 2011 Aug; 29(34):5666-74. PubMed ID: 21699951
[TBL] [Abstract][Full Text] [Related]
14. The induction of CD80 and apoptosis on B cells and CD40L in CD4+ T cells in response to seasonal influenza vaccination distinguishes responders versus non-responders in healthy controls and aviremic ART-treated HIV-infected individuals.
Powell AM; Luo Z; Martin L; Wan Z; Ma L; Liao G; Song Y; Li X; Michael Kilby J; Huang L; Jiang W
Vaccine; 2017 Feb; 35(5):831-841. PubMed ID: 28017428
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and safety of monovalent influenza A (H1N1) 2009 in HIV-infected Thai children.
Phongsamart W; Sirisanthana V; Wittawatmongkol O; Maleesatharn A; Sudjaritruk T; Chearskul P; Aurpibul L; Sirisanthana T; Chokephaibulkit K
Vaccine; 2011 Nov; 29(47):8705-11. PubMed ID: 21893147
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity and safety of inactivated monovalent 2009 H1N1 influenza A vaccine in immunocompromised children and young adults.
Hakim H; Allison KJ; Van De Velde LA; Li Y; Flynn PM; McCullers JA
Vaccine; 2012 Jan; 30(5):879-85. PubMed ID: 22155630
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity and safety of a split-virion quadrivalent influenza vaccine in adults 18-60 years of age in the Republic of Korea.
Choi WS; Noh JY; Lee J; Choi JY; Lee JS; Kim MS; Kim HS; Bang J; Lavis N; Kim WJ
Hum Vaccin Immunother; 2018 Mar; 14(3):587-592. PubMed ID: 28933625
[TBL] [Abstract][Full Text] [Related]
18. Pandemic influenza A H1N1 vaccine in recipients of solid organ transplants: immunogenicity and tolerability outcomes after vero cell derived, non-adjuvanted, whole-virion vaccination.
Lagler H; Wenisch JM; Tobudic S; Gualdoni GA; Rödler S; Rasoul-Rockenschaub S; Jaksch P; Redlberger-Fritz M; Popow-Kraupp T; Burgmann H
Vaccine; 2011 Sep; 29(40):6888-93. PubMed ID: 21803100
[TBL] [Abstract][Full Text] [Related]
19. Key differences in B cell activation patterns and immune correlates among treated HIV-infected patients versus healthy controls following influenza vaccination.
Luo Z; Ma L; Zhang L; Martin L; Wan Z; Warth S; Kilby A; Gao Y; Bhargava P; Li Z; Wu H; Meissner EG; Li Z; Kilby JM; Liao G; Jiang W
Vaccine; 2016 Apr; 34(16):1945-55. PubMed ID: 26721328
[TBL] [Abstract][Full Text] [Related]
20. Responses to pandemic ASO3-adjuvanted A/California/07/09 H1N1 influenza vaccine in human immunodeficiency virus-infected individuals.
Kelly D; Burt K; Missaghi B; Barrett L; Keynan Y; Fowke K; Grant M
BMC Immunol; 2012 Aug; 13():49. PubMed ID: 22937824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
